Social networks
391Activities
Technologies
Entity types
Location
31 Rue Gustave Eiffel, 38000 Grenoble, France
Grenoble
France
Employees
Scale: 2-10
Estimated: 3
Engaged corporates
18Added in Motherbase
2 months, 1 week agoBuilding a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance
Alpioner Therapeutics is a biotech company developing a whole-cell vaccine platform consisting of genetically optimized strains of human pathogens undergoing an attenuation process which delivers a Killed but Metabolically Active (KBMA) vaccine substance. This platform has already generated a first candidate targeting a human multi-resistant pathogen, Pseudomonas aeruginosa. It carries on the potential for further applications against other resistant pathogens.
Alpioner Therapeutics mission is to build a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance (AMR).
Alpioner Therapeutics is a biotechnology company developing the first KBMA vaccine candidate against pseudomonas aeruginosa
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Réseau SATT | Other 7 Apr 2024 | | ||
Toulouse Tech Transfer | Other 29 Feb 2024 | | ||
LUTECH | Other 29 Feb 2024 | | ||
SATT Nord | Other 7 Mar 2024 | | ||
SATT Aquitaine Science Transfert | Other 29 Feb 2024 | | ||
SATT AxLR | Other 29 Feb 2024 | | ||
CIC Bank, Banking | CIC Bank, Banking | Other 31 Mar 2024 | | |
PULSALYS Research, Research Services | PULSALYS Research, Research Services | Other 29 Feb 2024 | | |
SATT CONECTUS Research, Research Services | SATT CONECTUS Research, Research Services | Other 29 Feb 2024 | | |
Linksium Venture Capital and Private Equity Principals | Linksium Venture Capital and Private Equity Principals | Other 10 Jul 2024 | |